Pierre Legault - Net Worth and Insider Trading
Pierre Legault Net Worth
The estimated net worth of Pierre Legault is at least $630,080 dollars as of 2024-11-06. Pierre Legault is the Director of Syndax Pharmaceuticals Inc and owns about 32,000 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $630,080. Pierre Legault is also the Director of Bicycle Therapeutics PLC and owns about 0 shares of Bicycle Therapeutics PLC (BCYC) stock worth over $0. Details can be seen in Pierre Legault's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pierre Legault has not made any transactions after 2023-01-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pierre Legault
Pierre Legault Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pierre Legault owns 9 companies in total, including Urovant Sciences Ltd (UROV) , Syndax Pharmaceuticals Inc (SNDX) , and Bicycle Therapeutics PLC (BCYC) among others .
Click here to see the complete history of Pierre Legault’s form 4 insider trades.
Insider Ownership Summary of Pierre Legault
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
UROV | Urovant Sciences Ltd | 2020-07-21 | director |
SNDX | Syndax Pharmaceuticals Inc | 2023-01-13 | director |
BCYC | Bicycle Therapeutics PLC | 2021-12-22 | director |
2019-05-03 | director | ||
2018-03-26 | director | ||
2016-11-01 | director | ||
2015-11-10 | director & Chief Executive Officer | ||
2007-06-04 | Senior EVP & CAO | ||
2007-03-09 | director |
Pierre Legault Latest Holdings Summary
Pierre Legault currently owns a total of 2 stocks. Among these stocks, Pierre Legault owns 32,000 shares of Syndax Pharmaceuticals Inc (SNDX) as of January 13, 2023, with a value of $630,080 and a weighting of 100%. Pierre Legault also owns 0 shares of Bicycle Therapeutics PLC (BCYC) as of December 22, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Pierre Legault
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SNDX | Syndax Pharmaceuticals Inc | 2023-01-13 | 32,000 | 19.69 | 630,080 |
BCYC | Bicycle Therapeutics PLC | 2021-12-22 | 0 | 23.51 | 0 |
Holding Weightings of Pierre Legault
Pierre Legault Form 4 Trading Tracker
According to the SEC Form 4 filings, Pierre Legault has made a total of 2 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 39,000 shares on January 13, 2023, which brought Pierre Legault around $1 Million.
According to the SEC Form 4 filings, Pierre Legault has made a total of 6 transactions in Bicycle Therapeutics PLC (BCYC) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Bicycle Therapeutics PLC is the sale of 150,000 shares on December 22, 2021, which brought Pierre Legault around $9 Million.
Insider Trading History of Pierre Legault
- 1
Pierre Legault Trading Performance
Pierre Legault Ownership Network
Ownership Network List of Pierre Legault
Ownership Network Relation of Pierre Legault
Pierre Legault Owned Company Details
What does Urovant Sciences Ltd do?
Who are the key executives at Urovant Sciences Ltd?
Pierre Legault is the director of Urovant Sciences Ltd. Other key executives at Urovant Sciences Ltd include SVP & Commercial & USI Walt Johnston , CMO/Urovant Sciences & Inc. Haag-molkenteller Cornelia , and PFO;CFO/Urovant Sciences & Inc. Ajay Bansal .
Urovant Sciences Ltd (UROV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Urovant Sciences Ltd (UROV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Urovant Sciences Ltd (UROV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Urovant Sciences Ltd (UROV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Urovant Sciences Ltd Insider Transactions
Pierre Legault Mailing Address
Above is the net worth, insider trading, and ownership report for Pierre Legault. You might contact Pierre Legault via mailing address: P.o. Box 1028, C/o Stone Management Llc, Berwyne Pa 19312.